AccessibilityHelpAbout Us
Pro Medicus logo

Pro Medicus(ASX) PME

Market CapA$17.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+20,965%
5 Year+191%
1 Year-47%
1 Month-13%
A$165.57
-2.36%
-4.00Today
Pro Medicus last closing stock price
MetricPriceDate
Last closeAUD 165.572026-09-21
Pro Medicus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.1%AUD 165.402026-09-14
1 month-13.4%AUD 191.192026-08-21
3 month-4.05%AUD 172.562026-06-23
Year to date-24.67%AUD 219.792025-12-31
1 year-46.89%AUD 311.762025-09-19
3 year+133.35%AUD 70.952023-09-22
5 year+191.3%AUD 56.842021-09-22
Since inception+20,964.74%AUD 0.802000-10-10

Pro Medicus Financials at a Glance

Market Cap

A$17.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$474.67M

Net Income (TTM)

A$380.56M

EPS (TTM)

A$2.54

P/E Ratio

66.77

Dividend

A$0.69

Beta (Volatility)

0.10 (Low)

Price

A$165.57

Volume

104,461

Open

A$168.00

Previous Close

A$165.57

Daily Range

A$164.42 - A$169.00

52-Week Range

A$107.75 - A$321.27

Estimated Earnings Date

Feb 16, 2027

PME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pro Medicus

Pro Medicus Limited is a prominent provider of medical imaging software and services, established in 1983 and headquartered in Richmond, Australia. The company specializes in delivering advanced solutions to healthcare organizations across Australia, North America, and Europe, enhancing the efficiency of medical imaging processes.

Products and Services
  • Radiology Information Systems (RIS) for streamlined practice management
  • Promedicus.net, an e-health platform for enhanced patient care
  • Visage 7 imaging software for powerful visualization of medical images
Growth Outlook
  • Revenue increased to AUD 136.9 million in the latest quarter
  • Net income reached AUD 94.1 million, reflecting strong profitability
  • Consistent demand for imaging solutions supports future growth potential
Financial Highlights
  • Trailing twelve months revenue of AUD 536.5 million, showcasing robust performance
  • Net profit margin of 1.01, indicating effective cost management
  • Current ratio of 6.82, demonstrating strong liquidity position
Pro Medicus Limited has established itself as a leader in the healthcare information services sector, with a focus on innovative imaging solutions. The company's diverse product offerings cater to a wide range of healthcare providers, enhancing operational efficiency and patient outcomes. Recent financial performance highlights a significant increase in revenue and net income, underscoring the company's strong market position and growth potential. With a solid liquidity position and a commitment to innovation, Pro Medicus is well-positioned to capitalize on the growing demand for advanced medical imaging solutions.
AI Generated • Aug 22, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

153

CEO

Sam Aaron Hupert, MD

Website

www.promed.com.au

Headquarters

Richmond, VIC 3121, AU

PME Financials

Key Financial Metrics (TTM)

Gross Margin

80.69%

Operating Margin

74.94%

Net Income Margin

101.40%

Return on Equity

63.19%

Return on Capital

43.28%

Return on Assets

43.49%

Earnings Yield

1.50%

Dividend Yield

0.41%

Payout Ratio

24.41%

Stock Overview

Market Cap

A$17.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

104.47M

Volume

104.46K

Avg. Volume

291.07K

Financials (TTM)

Gross Profit

A$380.30M

Operating Income

A$353.81M

EBITDA

A$374.79M

Operating Cash Flow

A$255.39M

Capital Expenditure

-A$883.00K

Free Cash Flow

A$254.51M

Cash & ST Invst.

A$250.62M

Total Debt

A$2.23M

Pro Medicus Performance Analysis

Pro Medicus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 124,900,00033.6%
20242024-06-30AUD 161,501,00029.3%
20252025-06-30AUD 212,980,00031.9%
20262026-06-30AUD 261,688,00022.9%
Pro Medicus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3111.2%
Q42025-06-3019.1%
Q22025-12-317.8%
Q42026-06-309.7%
Pro Medicus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.5836.4%
20242024-06-30AUD 0.7936.4%
20252025-06-30AUD 1.1039.2%
20262026-06-30AUD 2.54130.3%
Pro Medicus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-318.9%
Q42025-06-3024.5%
Q22025-12-31168.9%
Q42026-06-30-45.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$136.91M

+56.7%

Gross Profit

A$114.99M

+69.9%

Gross Margin

83.99%

N/A

Market Cap

A$17.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$115.78M

N/A

Employees

153

N/A

Net Income

A$94.12M

+102.2%

EBITDA

A$109.87M

+56.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$250.62M

+61.3%

Total Debt

A$2.23M

+7.8%

Accounts Receivable

A$100.35M

+104.0%

Inventory

A$0.00

-100.0%

Long Term Debt

A$1.46M

-3.6%

Short Term Debt

A$769.00K

+39.1%

Return on Assets

43.49%

N/A

Return on Invested Capital

35.15%

N/A

Free Cash Flow

A$66.95M

+27.7%

Operating Cash Flow

A$67.14M

+20.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FPH.AXFisher & Paykel Healthcare Corporation Limited
A$35.74+1.51%
COH.AXCochlear Limited
A$140.95+5.27%
SIG.AXSigma Healthcare Limited
A$2.53-0.78%
CGS.AXCogstate Limited
A$3.37-1.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
GRMLGreenland Mines
$10.15+256.14%
WBDWarner Bros. Discovery
$30.55+9.89%
INTCIntel
$124.17+14.34%
BITOProShares Trust - ProShares Bitcoin ETF
$11.55+5.77%

Questions About PME

What is the current price of Pro Medicus?

Pro Medicus is trading at A$165.57 per share.

What is the 52-week range for Pro Medicus?

Over the past 52 weeks, Pro Medicus has traded between A$107.75 and A$321.27.

How much debt does Pro Medicus have?

As of the most recent reporting period, Pro Medicus reported total debt of A$2.23M.

How much cash does Pro Medicus have on hand?

Pro Medicus reported A$146.48M in cash and cash equivalents in its most recent financial results.

What is Pro Medicus’s dividend yield?

Pro Medicus currently has a dividend yield of 0.41%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services